5 completed. 5 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 5 | Completed 5 |
Follow Chikungunya Fever: new trials by email Literature Review of Chikungunya Fever trials Research Report on Chikungunya Fever
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years CHIKV VLP/adjuvant, Placebo - Chikungunya Virus | Phase 3 | Completed | Bavarian Nordic | 413 | 2022-05-12 | 2024-12-13 |
| A Multicenter Study to Evaluate Safety and Immunogenicity of a Live-attenuated Chikungunya Vaccine in Adolescents Active, Placebo - Chikungunya | Phase 3 | Completed | Butantan Institute | 754 | 2022-02-14 | 2026-06-04 |
| A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine) CHIKV VLP/adjuvant, Placebo - Chikungunya Virus | Phase 3 | Completed | Bavarian Nordic | 3258 | 2021-09-29 | 2024-08-30 |
| Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults Biological Vaccine VLA1553 - Chikungunya Virus Infection | Phase 3 | Completed | Valneva Austria GmbH | 409 | 2021-02-22 | 2023-09-28 |
| Pivotal Study to Evaluate Safety and Immunogenicity of a Live-Attenuated Chikungunya Virus Vaccine Candidate in Adults VLA1553, Placebo - Chikungunya Virus Infection | Phase 3 | Completed | Valneva Austria GmbH | 4128 | 2020-09-17 | 2023-06-28 |
Alphavirus Infections (5) · Arbovirus Infections (5) · Infections (5) · Mosquito-Borne Diseases (5) · RNA Virus Infections (5) · Togaviridae Infections (5) · Vector Borne Diseases (5) · Virus Diseases (5)
Exercise (1)
Bavarian Nordic (2) · Valneva Austria GmbH (2) · Butantan Institute (1)
United States (4) · Brazil (1)
Patrick Ajiboye, MD (2) · Fernanda C Boulos, MD, MSc (1)
PMID 35709798, PMID 37321235, PMID 39004524, PMID 39243794, PMID 39998495, PMID 40158524, PMID 40158526, PMID 41380703